ZA924811B
(en)
*
|
1991-06-28 |
1993-12-29 |
Endorecherche Inc |
Controlled release systems and low dose androgens
|
HU222501B1
(hu)
*
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
US20020091155A1
(en)
*
|
1995-06-22 |
2002-07-11 |
Btg Pharmaceutical Corp. |
Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
|
WO1994016709A2
(en)
*
|
1993-01-19 |
1994-08-04 |
Endorecherche Inc. |
Therapeutic uses and delivery systems of dehydroepiandrosterone
|
US5776923A
(en)
*
|
1993-01-19 |
1998-07-07 |
Endorecherche, Inc. |
Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
|
US6407082B1
(en)
*
|
1996-09-13 |
2002-06-18 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a vitamin D compound
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US5574011A
(en)
*
|
1995-04-04 |
1996-11-12 |
Tien; Henry C. |
Compositions and methods for the treatment of male-pattern baldness
|
US5910492A
(en)
*
|
1995-06-05 |
1999-06-08 |
Takeda Chemical Industries, Ltd. |
Osteogenic promoting pharmaceutical composition
|
WO1997004752A1
(en)
*
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
US6028064A
(en)
*
|
1996-09-13 |
2000-02-22 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of progestin products
|
US6034074A
(en)
|
1996-09-13 |
2000-03-07 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a Vitamin D compound
|
US6765002B2
(en)
|
2000-03-21 |
2004-07-20 |
Gustavo Rodriguez |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
|
US6511970B1
(en)
|
1996-09-13 |
2003-01-28 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
|
US6576659B1
(en)
*
|
1996-12-05 |
2003-06-10 |
Bio-Technology General Corp. |
Use of oxandrolone in the treatment of burns an other wounds
|
US5855920A
(en)
*
|
1996-12-13 |
1999-01-05 |
Chein; Edmund Y. M. |
Total hormone replacement therapy
|
US6416778B1
(en)
|
1997-01-24 |
2002-07-09 |
Femmepharma |
Pharmaceutical preparations and methods for their regional administration
|
US6028057A
(en)
*
|
1998-02-19 |
2000-02-22 |
Thorn Bioscience, Llc |
Regulation of estrus and ovulation in gilts
|
JP2002506077A
(ja)
|
1998-03-11 |
2002-02-26 |
アンドルシェルシュ・インコーポレイテッド |
タイプ5およびタイプ317β−ヒドロキシステロイドデヒドロゲナーゼのインヒビターおよびその使用法
|
KR100293504B1
(ko)
|
1998-06-05 |
2001-07-12 |
김윤 |
서방형전립선염치료제조성물
|
US7005428B1
(en)
|
1998-06-11 |
2006-02-28 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
US6294188B1
(en)
|
1998-07-09 |
2001-09-25 |
Aviana Biopharm Inc. |
Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
|
JP2002520346A
(ja)
*
|
1998-07-17 |
2002-07-09 |
ファルマシア・アンド・アップジョン・カンパニー |
避妊用皮下メドロキシプロゲステロンアセタート
|
EP1052980A1
(en)
*
|
1998-10-09 |
2000-11-22 |
PHARMACIA & UPJOHN COMPANY |
Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
US6498153B1
(en)
|
1998-12-31 |
2002-12-24 |
Akzo Nobel N.V. |
Extended release growth promoting two component composition
|
US7018654B2
(en)
*
|
1999-03-05 |
2006-03-28 |
New River Pharmaceuticals Inc. |
Pharmaceutical composition containing an active agent in an amino acid copolymer structure
|
US6716452B1
(en)
|
2000-08-22 |
2004-04-06 |
New River Pharmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US6613758B1
(en)
|
1999-04-02 |
2003-09-02 |
Barr Laboratories, Inc. |
Method for treating osteoporosis in castrated prostatic cancer patients
|
AU3957400A
(en)
*
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
PT1175433E
(pt)
|
1999-05-04 |
2005-11-30 |
Strakan Int Ltd |
Glicosidos androgenos e sua actividade androgenica
|
US6187750B1
(en)
|
1999-08-25 |
2001-02-13 |
Everyoung Technologies, Inc. |
Method of hormone treatment for patients with symptoms consistent with multiple sclerosis
|
US6846496B1
(en)
|
1999-10-15 |
2005-01-25 |
Orion Corporation |
Treatment of osteoporosis
|
US6705757B2
(en)
*
|
1999-11-12 |
2004-03-16 |
Alkermes Controlled Therapeutics, Inc. Ii |
Method and apparatus for preparing microparticles using in-line solvent extraction
|
US6495166B1
(en)
|
1999-11-12 |
2002-12-17 |
Alkermes Controlled Therapeutics Inc. |
Apparatus and method for preparing microparticles using in-line solvent extraction
|
US6331317B1
(en)
|
1999-11-12 |
2001-12-18 |
Alkermes Controlled Therapeutics Ii Inc. |
Apparatus and method for preparing microparticles
|
US6682754B2
(en)
*
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
JP2003518485A
(ja)
|
1999-12-23 |
2003-06-10 |
ファイザー・プロダクツ・インク |
向上された薬物濃度を与える医薬組成物
|
US6562790B2
(en)
|
2000-02-05 |
2003-05-13 |
Chein Edmund Y M |
Hormone therapy methods and hormone products for abating coronary artery blockage
|
AU2001241779A1
(en)
|
2000-02-25 |
2001-09-03 |
Hollis-Eden Pharmaceuticals, Inc. |
Method of treatment of prostate cancer
|
US7989436B2
(en)
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US6660726B2
(en)
*
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US20010044431A1
(en)
*
|
2000-03-21 |
2001-11-22 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
FR2811218B1
(fr)
|
2000-07-05 |
2003-02-28 |
Patrice Suslian |
Dispositif implantable destine a corriger l'incontinence urinaire
|
DE60127139T2
(de)
*
|
2000-07-14 |
2007-12-13 |
Novo Nordisk A/S |
Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
ES2294026T3
(es)
*
|
2000-09-06 |
2008-04-01 |
Ap Pharma, Inc. |
Polimeros degradables de poliacetal.
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US20060205995A1
(en)
|
2000-10-12 |
2006-09-14 |
Gyne Ideas Limited |
Apparatus and method for treating female urinary incontinence
|
GB0025068D0
(en)
|
2000-10-12 |
2000-11-29 |
Browning Healthcare Ltd |
Apparatus and method for treating female urinary incontinence
|
US8167785B2
(en)
|
2000-10-12 |
2012-05-01 |
Coloplast A/S |
Urethral support system
|
US8394813B2
(en)
|
2000-11-14 |
2013-03-12 |
Shire Llc |
Active agent delivery systems and methods for protecting and administering active agents
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
GB0108088D0
(en)
|
2001-03-30 |
2001-05-23 |
Browning Healthcare Ltd |
Surgical implant
|
US20060014697A1
(en)
*
|
2001-08-22 |
2006-01-19 |
Travis Mickle |
Pharmaceutical compositions for prevention of overdose or abuse
|
US7169752B2
(en)
*
|
2003-09-30 |
2007-01-30 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
CA2471400A1
(en)
|
2001-12-20 |
2003-07-03 |
Femmepharma, Inc. |
Vaginal delivery of drugs
|
CA2478165A1
(en)
*
|
2002-03-11 |
2003-09-25 |
Janssen Pharmaceutica N.V. |
Sulfatase inhibiting progestogen-only contraceptive regimens
|
EP1492459A2
(en)
*
|
2002-04-11 |
2005-01-05 |
Gyne Ideas Limited |
Apparatus and method for treating female urinary incontinence
|
DE60311801T2
(de)
*
|
2002-05-02 |
2007-11-08 |
PR Pharmaceuticals, Inc., Fort Collins |
Zusammensetzungen aus östradiol-metaboliten mit kontrollierter freisetzung
|
EP1829529A1
(en)
*
|
2002-05-03 |
2007-09-05 |
PR Pharmaceuticals, Inc. |
Controlled release compositions of estradiol metabolites
|
JP4452180B2
(ja)
|
2002-08-02 |
2010-04-21 |
シー・アール・バード・インコーポレーテッド |
女性の尿道を支持するためのシステム
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
CA2511995C
(en)
*
|
2003-01-02 |
2012-03-13 |
Femmepharma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
GB0307082D0
(en)
|
2003-03-27 |
2003-04-30 |
Gyne Ideas Ltd |
Drug delivery device and method
|
US6992075B2
(en)
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
CA2521471A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Barr Laboratories, Inc. |
Methods of administering estrogens and progestins
|
US7056591B1
(en)
|
2003-07-30 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
|
AU2004267956B2
(en)
*
|
2003-09-03 |
2010-09-16 |
Miscon Trading S.A. |
Methods for the treatment of endometriosis
|
EP3025722B1
(en)
|
2003-10-03 |
2020-05-27 |
Thorn BioScience, LLC |
Process for the synchronization of ovulation for timed breeding without heat detection
|
US20070160622A1
(en)
*
|
2005-12-07 |
2007-07-12 |
Medivas, Llc |
Method for assembling a polymer-biologic delivery composition
|
US9114198B2
(en)
*
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
US7220816B2
(en)
*
|
2003-12-16 |
2007-05-22 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same
|
US7435788B2
(en)
*
|
2003-12-19 |
2008-10-14 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
|
JP2007517550A
(ja)
|
2004-01-02 |
2007-07-05 |
アドヴァンスド カーディオヴァスキュラー システムズ, インコーポレイテッド |
高比重リポ蛋白をコーティングした医療デバイス
|
US8685431B2
(en)
*
|
2004-03-16 |
2014-04-01 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
|
US8778014B1
(en)
|
2004-03-31 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for preventing balloon damage to polymer coated stents
|
PT1734971E
(pt)
|
2004-04-15 |
2012-02-02 |
Amylin Pharmaceuticals Inc |
Dispositivo de libertação sustentada baseado em polímero
|
US7334330B2
(en)
*
|
2004-04-28 |
2008-02-26 |
Siemens Power Generation, Inc. |
Thermally insulating layer incorporating a distinguishing agent and method for inspecting the same
|
US20050288481A1
(en)
*
|
2004-04-30 |
2005-12-29 |
Desnoyer Jessica R |
Design of poly(ester amides) for the control of agent-release from polymeric compositions
|
US7820732B2
(en)
*
|
2004-04-30 |
2010-10-26 |
Advanced Cardiovascular Systems, Inc. |
Methods for modulating thermal and mechanical properties of coatings on implantable devices
|
GB0411360D0
(en)
*
|
2004-05-21 |
2004-06-23 |
Mpathy Medical Devices Ltd |
Implant
|
US20050271700A1
(en)
*
|
2004-06-03 |
2005-12-08 |
Desnoyer Jessica R |
Poly(ester amide) coating composition for implantable devices
|
US20050287184A1
(en)
|
2004-06-29 |
2005-12-29 |
Hossainy Syed F A |
Drug-delivery stent formulations for restenosis and vulnerable plaque
|
US7311980B1
(en)
|
2004-08-02 |
2007-12-25 |
Advanced Cardiovascular Systems, Inc. |
Polyactive/polylactic acid coatings for an implantable device
|
ES2432556T3
(es)
|
2004-08-04 |
2013-12-04 |
Evonik Corporation |
Métodos para fabricar dispositivos de suministro y sus dispositivos
|
US7166680B2
(en)
*
|
2004-10-06 |
2007-01-23 |
Advanced Cardiovascular Systems, Inc. |
Blends of poly(ester amide) polymers
|
CN106038572A
(zh)
|
2004-10-20 |
2016-10-26 |
恩多研究公司 |
性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
|
US8603634B2
(en)
*
|
2004-10-27 |
2013-12-10 |
Abbott Cardiovascular Systems Inc. |
End-capped poly(ester amide) copolymers
|
US20060089485A1
(en)
*
|
2004-10-27 |
2006-04-27 |
Desnoyer Jessica R |
End-capped poly(ester amide) copolymers
|
US7390497B2
(en)
*
|
2004-10-29 |
2008-06-24 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) filler blends for modulation of coating properties
|
US8609123B2
(en)
*
|
2004-11-29 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Derivatized poly(ester amide) as a biobeneficial coating
|
US7419504B2
(en)
*
|
2004-12-27 |
2008-09-02 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) block copolymers
|
US8007775B2
(en)
*
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
US8128952B2
(en)
*
|
2005-01-12 |
2012-03-06 |
Clemson University Research Foundation |
Ligand-mediated controlled drug delivery
|
US7202325B2
(en)
*
|
2005-01-14 |
2007-04-10 |
Advanced Cardiovascular Systems, Inc. |
Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles
|
EP1853272A1
(en)
*
|
2005-02-03 |
2007-11-14 |
Duramed Pharmaceuticals, Inc. |
Compositions of unconjugated estrogens and methods for their use
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP1848410A4
(en)
*
|
2005-02-17 |
2011-11-09 |
Medivas Llc |
COMPOSITIONS FOR DISPENSING POLYMER PARTICLES AND APPLICATION METHOD THEREFOR
|
US20070020312A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Desnoyer Jessica R |
Method of fabricating a bioactive agent-releasing implantable medical device
|
US8377462B2
(en)
*
|
2005-07-29 |
2013-02-19 |
Advanced Cardiovascular Systems, Inc. |
PEA-TEMPO/PEA-BZ coatings for controlled delivery of drug from implantable medical devices
|
EP1933881B1
(en)
*
|
2005-09-22 |
2019-03-13 |
Medivas, LLC |
Solid polymer delivery compositions and methods for use thereof
|
CA2623198C
(en)
|
2005-09-22 |
2014-08-05 |
Medivas, Llc |
Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
|
US20070077269A1
(en)
*
|
2005-10-04 |
2007-04-05 |
Woodward John R |
Method of birth control and hormone regulation
|
JP5449775B2
(ja)
|
2005-10-19 |
2014-03-19 |
チャバフ ピーティーワイ エルティーディー |
乳癌の治療に使用されるアロマターゼ阻害薬による副作用の低減
|
US20070135909A1
(en)
*
|
2005-12-08 |
2007-06-14 |
Desnoyer Jessica R |
Adhesion polymers to improve stent retention
|
US20070197435A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Webel Stephen K |
Process for the synchronization of ovulation for timed breeding without heat detection
|
US7910152B2
(en)
*
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
EP2019645A4
(en)
*
|
2006-05-02 |
2013-03-06 |
Medivas Llc |
RELEASE OF OPHTHALMOLOGICAL ACTIVITIES OUTSIDE OR WITHIN THE EYE
|
WO2007133616A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Medivas, Llc |
Biodegradable water soluble polymers
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
US7771739B2
(en)
*
|
2006-06-30 |
2010-08-10 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices comprising semi-crystalline poly(ester-amide)
|
US9028859B2
(en)
*
|
2006-07-07 |
2015-05-12 |
Advanced Cardiovascular Systems, Inc. |
Phase-separated block copolymer coatings for implantable medical devices
|
US20090181063A1
(en)
*
|
2006-07-13 |
2009-07-16 |
Michael Huy Ngo |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
US8030436B2
(en)
*
|
2006-07-13 |
2011-10-04 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester-amide) elastomers and their use with implantable medical devices
|
US7731987B2
(en)
*
|
2006-07-13 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
US20080014245A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Stephen Pacetti |
Drug-eluting implantable medical device with free radical scavenger for protecting drugs during sterilization and related method
|
NZ574524A
(en)
|
2006-08-09 |
2011-07-29 |
Intarcia Therapeutics Inc |
Piston assembly for positioning lumen of a reservoir for an osmotic delivery having a columnar body and a spring
|
WO2008083158A2
(en)
*
|
2006-12-26 |
2008-07-10 |
Femmepharma Holding Company, Inc. |
Topical administration of danazol
|
US20080175882A1
(en)
*
|
2007-01-23 |
2008-07-24 |
Trollsas Mikael O |
Polymers of aliphatic thioester
|
JP2010522196A
(ja)
*
|
2007-03-22 |
2010-07-01 |
アルカームズ,インコーポレイテッド |
コアセルベーション工程
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
US20080306584A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Pamela Kramer-Brown |
Implantable medical devices for local and regional treatment
|
US8252361B2
(en)
*
|
2007-06-05 |
2012-08-28 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices for local and regional treatment
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
US9737638B2
(en)
|
2007-06-20 |
2017-08-22 |
Abbott Cardiovascular Systems, Inc. |
Polyester amide copolymers having free carboxylic acid pendant groups
|
US7927621B2
(en)
*
|
2007-06-25 |
2011-04-19 |
Abbott Cardiovascular Systems Inc. |
Thioester-ester-amide copolymers
|
US20090029937A1
(en)
*
|
2007-07-24 |
2009-01-29 |
Cornell University |
Biodegradable cationic polymer gene transfer compositions and methods of use
|
US8268806B2
(en)
|
2007-08-10 |
2012-09-18 |
Endorecherche, Inc. |
Pharmaceutical compositions
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US8889172B1
(en)
|
2008-04-30 |
2014-11-18 |
Abbott Cardiovascular Systems Inc. |
Amorphous or semi-crystalline poly(ester amide) polymer with a high glass transition temperature
|
US8765162B2
(en)
*
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
EP2323671A4
(en)
*
|
2008-08-13 |
2012-09-26 |
Medivas Llc |
BIODEGRADABLE AABB POLY (DEPSIPEPTIDE) POLYMERS AND METHOD FOR THEIR USE
|
US20100047319A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Michael Huy Ngo |
Biodegradable Poly(Ester-Amide) And Poly(Amide) Coatings For Implantable Medical Devices With Enhanced Bioabsorption Times
|
US20120114757A1
(en)
|
2009-02-18 |
2012-05-10 |
Bayer Pharma Aktiengesellschaft |
Particles comprising drospirenone encapsulated in a polymer
|
EP2398461A1
(en)
|
2009-02-18 |
2011-12-28 |
Bayer Pharma Aktiengesellschaft |
Formulation comprising drospirenone for subcutaneous or intramuscular administration
|
RU2568839C2
(ru)
|
2009-04-23 |
2015-11-20 |
ДжейБиЭс Юнайтид Энимал Хэлс II ЛЛК |
Способ и композиция для синхронизации времени осеменения
|
US20110003000A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Femmepharma Holding Company, Inc. |
Transvaginal Delivery of Drugs
|
LT2462246T
(lt)
|
2009-09-28 |
2017-11-27 |
Intarcia Therapeutics, Inc |
Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
EP2723800B1
(en)
|
2011-06-23 |
2015-10-07 |
DSM IP Assets B.V. |
Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
CU24287B1
(es)
*
|
2012-06-27 |
2017-12-08 |
Medincell |
Suministro de fármaco biodegradable para las composiciones hidrofóbicas
|
US9724380B2
(en)
|
2012-11-28 |
2017-08-08 |
Jbs United Animal Health Ii Llc |
Method and compositions for synchronizing time of insemination in gilts
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
AU2015336929B2
(en)
|
2014-10-22 |
2021-03-18 |
Havah Therapeutics Pty Ltd |
Methods of reducing mammographic breast density and/or breast cancer risk
|
US10434071B2
(en)
|
2014-12-18 |
2019-10-08 |
Dsm Ip Assets, B.V. |
Drug delivery system for delivery of acid sensitivity drugs
|
JP6993235B2
(ja)
|
2015-06-03 |
2022-01-13 |
インターシア セラピューティクス,インコーポレイティド |
インプラントの設置及び撤去システム
|
AU2016343297A1
(en)
|
2015-10-22 |
2018-05-10 |
Havah Therapeutics Pty Ltd |
Methods of reducing mammographic breast density and/or breast cancer risk
|
PT3377041T
(pt)
|
2015-11-16 |
2023-12-15 |
Maria Pereira Da Cruz Alves Garcia |
Método para morcelação e/ou direcionamento de princípios farmaceuticamente ativos ao tecido sinovial
|
EP3458084B1
(en)
|
2016-05-16 |
2020-04-01 |
Intarcia Therapeutics, Inc |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
EP3976048A4
(en)
|
2019-06-03 |
2023-07-12 |
Havah Therapeutics Pty Ltd |
PHARMACEUTICAL FORMULATIONS AND SYSTEMS FOR THE ADMINISTRATION OF AN ANDROGEN AGENT AND AN AROMATASE INHIBITOR, AND METHODS OF USE
|